FTRE Stock Analysis: Buy, Sell, or Hold?
FTRE - Fortrea Holdings Inc. Common Stock
$17.86
0.10 (0.56%)
▲
5d:
+0.06%
30d:
+9.3%
90d:
+94.55%
HOLD
MODERATE Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 05, 2026
21d
Get Alerted When FTRE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: FTRE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: FTRE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$31.66
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$19.66
9.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: FTRE is currently trading at $17.86, which is considered extended relative to its 30-day fair value range of $16.11 to $17.67. The stock's valuation (Forward PE: 16.6) is in line with its historical norms (15.1). At these levels, the market is pricing in 3.2% annual earnings growth.
Technical Outlook: Technically, FTRE is in a strong uptrend. The price is approaching resistance at $17.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, FTRE is in a strong uptrend. The price is approaching resistance at $17.56. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$16.11 -
$17.67
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
47.1%
All Signals
- BEARISH: Price extended above range
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BEARISH: Trading above Wall St target ($16.48)
- BULLISH: Expecting earnings turnaround to 3.2% growth with -2.3% revenue growth
Trading Range Analysis
30-Day Trading Range
$16.11 -
$17.67
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$13.11
Resistance Level
$17.56
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
16.59
Wall Street Target
$16.48
(-7.7%)
Revenue Growth (YoY)
-2.3%
Earnings Growth (YoY)
-57.4%
Profit Margin
-16.5%
Valuation Premium vs History
+3.2% premium
PE vs Historical
16.6 vs 15.1
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+3.2%
(market-implied from PE analysis)
1-Year Target
$18.43
(+3%)
2-Year Target
$19.02
(+7%)
3-Year Target
$19.63
(+10%)
3-Yr Target (if PE normalizes)
(PE: 17→15)
PE COMPRESSION
$17.87
(+0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.8, Growth: 33.5%)
$55.76
(+212%)
Base:
(SPY PE: 16.6, Growth: 33.5%)
$42.46
(+138%)
Bear:
(PE: 14.1, Growth: 33.5%)
$36.10
(+102%)
Share & Embed Analysis
Last updated: July 14, 2026 12:38 AM ET
Data refreshes hourly during market hours. Next update: 1:38 AM
Data refreshes hourly during market hours. Next update: 1:38 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is FTRE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Jill G Mcconnell
SELL
1804 shares
2026-03-16
Jill G Mcconnell
SELL
5061 shares
2026-03-10
Robert Parks
SELL
1927 shares
2026-03-10
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 57 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$555 | 57 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$81 | 57 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$108 | 60 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$28 | 60 HOLD |
